General MedicationsINHALATIONGeneric
ALUPENT
METAPROTERENOL SULFATE
Standard Dose
0.6%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview ALUPENT is listed in Drugs@FDA under application 018761 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient METAPROTERENOL SULFATE Form and strength SOLUTION;INHALATION - 0.6% Sponsor BOEHRINGER INGELHEIM Submission history Latest submission status date: 2002-01-23 00:00:00.
Structured Monograph
Clinical summary
Approval overview ALUPENT is listed in Drugs@FDA under application 018761 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient METAPROTERENOL SULFATE Form and strength SOLUTION;INHALATION - 0.6% Sponsor BOEHRINGER INGELHEIM Submission history Latest submission status date: 2002-01-23 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.